Merck. Vioxx

On Tuesday, November 22, Merck announced that it had reached a half-billion-dollar agreement with numerous state governments and with the federal government to settle civil charges that the company had illegally promoted Vioxx for off-label uses and that it had misrepresented the drug's risks.